NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)

NEXTURNBIOSCIENCE Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,602	13,737	10,644	20,632	52,700
Short-Term Investments	5,570	2,260	12,425	11,500	-
Trading Asset Securities	19,690	15,144	5,078	9,051	1,260
Cash & Short-Term Investments	35,863	31,141	28,147	41,184	53,960
Cash Growth	15.16%	10.64%	-31.66%	-23.68%	809.25%
Accounts Receivable	3,347	6,713	5,963	2,753	3,085
Other Receivables	1,117	958.61	2,081	1,229	-
Receivables	8,622	8,701	8,353	4,301	4,788
Inventory	8,438	6,247	7,023	5,352	6,982
Prepaid Expenses	67.35	75.47	121.12	51.8	19.25
Other Current Assets	117.25	612.59	322.12	57.62	1,037
Total Current Assets	53,107	46,777	43,966	50,946	66,786
Property, Plant & Equipment	27,227	27,955	28,628	12,662	16,043
Long-Term Investments	65,722	83,476	42,099	55,221	3,650
Goodwill	1,656	1,656	1,656	-	-
Other Intangible Assets	993.89	1,168	2,205	123.23	136.15
Long-Term Accounts Receivable	82,213	81,191	80,238	-	-
Long-Term Deferred Tax Assets	-	-	-	509.21	798.98
Long-Term Deferred Charges	0	0	0	0	0
Other Long-Term Assets	2,081	1,771	1,466	19,487	11,937
Total Assets	233,037	243,994	200,257	138,949	99,351
Accounts Payable	2,059	2,882	4,147	946.83	717.07
Accrued Expenses	377.72	555.68	593.37	236.14	118.81
Short-Term Debt	16,096	10,846	8,236	25,456	-
Current Portion of Long-Term Debt	-	64,375	625	-	-
Current Portion of Leases	874.01	798.78	803.49	732.96	22.52
Current Income Taxes Payable	322.47	3,274	8.2	127.62	-
Current Unearned Revenue	32.62	87.83	42.71	-	40.02
Other Current Liabilities	3,072	10,854	5,246	15,718	1,170
Total Current Liabilities	22,833	93,672	19,702	43,218	2,069
Long-Term Debt	64,000	-	64,375	-	-
Long-Term Leases	253.39	749.74	1,519	2,186	17.87
Long-Term Deferred Tax Liabilities	4,058	6,553	2,046	-	-
Other Long-Term Liabilities	5,269	5,006	3,922	578.85	304.8
Total Liabilities	96,413	105,981	91,983	46,214	2,583
Common Stock	30,427	23,509	19,427	16,610	5,923
Additional Paid-In Capital	65,394	61,033	45,093	35,733	46,494
Retained Earnings	39,723	53,083	43,821	46,734	51,341
Treasury Stock	-81.25	-81.25	-	-6,990	-6,990
Comprehensive Income & Other	1,161	470	-66.18	646.76	-0
Shareholders' Equity	136,624	138,014	108,274	92,735	96,768
Total Liabilities & Equity	233,037	243,994	200,257	138,949	99,351
Total Debt	81,223	76,769	75,558	28,375	40.39
Net Cash (Debt)	-45,361	-45,628	-47,412	12,808	53,920
Net Cash Growth	-	-	-	-76.25%	808.57%
Net Cash Per Share	-4149.54	-4523.61	-6984.29	1997.46	8408.77
Filing Date Shares Outstanding	12.16	9.4	7.77	6.41	6.41
Total Common Shares Outstanding	12.16	9.4	7.77	6.41	6.41
Working Capital	30,274	-46,895	24,264	7,728	64,717
Book Value Per Share	11231.71	14686.92	13933.75	14462.04	15090.95
Tangible Book Value	133,974	135,190	104,414	92,612	96,632
Tangible Book Value Per Share	11013.90	14386.39	13436.98	14442.82	15069.72
Land	19,143	19,143	19,143	5,013	9,767
Buildings	7,938	7,938	8,071	4,426	6,661
Machinery	9,942	9,625	11,114	5,451	5,497
Construction In Progress	-	82.5	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.